Choosing an Alzheimer's Hospital in China: Memory Assessment, Antibody Treatment, and Care Support

Choosing a hospital for Alzheimer's disease starts with the problem the visit needs to solve. One family needs the diagnosis reconsidered, another wants an antibody assessment, and another is struggling with sleepless nights, agitation, or unsustainable caregiving. The appropriate first clinic and supporting team can differ substantially. A hospital's reputation may narrow the search, but the relevant service still needs to be identified.

Key takeaways

These excerpts come from the original article. Read the full sections below for context.

“Does this blood result need further confirmation?”, “Why is the patient repeatedly fainting on treatment?”, or “Can antibody care continue in the home country?” helps a hospital route the request. A general request for the best expert gives less clinical direction. Prepare a one-page account of symptom onset, affected activities, existing diagnoses, treatment history, and the main purpose of the visit.
Joint assessment may help when cognitive difficulties intersect with mood, sleep, neurological signs, medication burden, or other diseases. West China's published memory-MDT description explains a coordinated approach, while its broader MDT information describes screening of records. This is a reminder that a multidisciplinary consultation should have a clinical question to resolve. West China memory MDT
After consultations, compare how clearly each plan explains the diagnosis, rationale for treatment, monitoring, expected burden, and continuation at home. If opinions differ, identify whether the disagreement concerns stage, imaging, interpretation of biomarkers, or inconsistent information about daily function. This can show whether another assessment would add value.

Quick answer

Full guide

A useful assessment should explain the diagnostic evidence, current stage, reasonable treatment options, and what happens after the patient goes home. A recommendation for a medicine or device without a clear account of function and possible alternative causes leaves important work unfinished. DETeCD-ADRD diagnostic guideline

Define two or three questions before booking

“Does this blood result need further confirmation?”, “Why is the patient repeatedly fainting on treatment?”, or “Can antibody care continue in the home country?” helps a hospital route the request. A general request for the best expert gives less clinical direction. Prepare a one-page account of symptom onset, affected activities, existing diagnoses, treatment history, and the main purpose of the visit.

Rapid deterioration over hours or days, new one-sided weakness, or reduced consciousness requires assessment of the acute problem. It should not wait for a planned international memory-clinic appointment. Emergency care and a second opinion for a stable patient follow different pathways.

A memory assessment should connect scores with everyday function

Cognitive testing needs to account for language, education, hearing, and vision. International patients should ask whether assessment is available in their primary language and how previous test versions will be documented. A family member translating questions during a visit does not automatically make the result directly comparable with a score obtained in another language.

Care partners can explain concrete changes: someone else now handles bills, medicines are sometimes taken twice, or familiar journeys have become difficult. Their information complements the patient's account rather than replacing the patient's opportunity to speak. The team should be able to discuss differences between these accounts and incorporate them into a practical plan. NIA assessment guidance

Four institutions with relevant published information

The examples below are based on professional or service information, not a ranking. Current appointments, acceptance of international patients, and particular drug stocks have not been confirmed. Select enquiries according to the clinical problem and geography rather than trying to collect visits at every institution.

Institution	Verified public information	Useful question for the hospital
Peking Union Medical College Hospital, Beijing	A 2026 report of multidisciplinary lecanemab real-world research; an official international patient route	Which clinic should assess this diagnosis or treatment request, and can records be submitted first?
Huashan Hospital, Fudan University, Shanghai	Participation in a seven-center Chinese lecanemab safety and short-term outcome study	Which team and campus currently provide assessment and continuing monitoring?
West China Hospital, Sichuan University, Chengdu	An official neurocognitive disorders service description and multidisciplinary memory care	Does this complex case need a specialty visit or an MDT review, and is prior record screening required?
Beijing Anding Hospital, Capital Medical University, Beijing	Published descriptions of geriatric memory, multidisciplinary mental health, and nursing support clinics	How should an assessment focused on agitation, mood, or caregiving difficulty be arranged?

The supporting sources are the PUMCH research report, the multicenter study involving Huashan, West China's neurocognitive service description, and Anding Hospital's geriatric outpatient information. Historical service-development descriptions establish a relevant professional focus; they do not confirm today's appointment arrangements.

Read hospital research as evidence of experience, not a personal guarantee

Relevant publications can show that a team has worked with the condition or treatment. They cannot promise that an individual patient will have the same outcome. The PUMCH report concerns selected treated patients and follow-up, while the seven-center study has its own inclusion criteria, observation period, and analysis. Comparing their adverse-event percentages as a hospital safety league table would be misleading.

A reported change on amyloid PET also does not mean that every participant regained daily abilities. Ask how the team selects patients, monitors them, and handles complications, including cases in which treatment never began or was interrupted. These processes are more useful for a consultation than converting an average study result into a personal success rate.

The same principle applies when a hospital announces an early prescription or a new service. Such an announcement may identify a place to enquire, but it does not tell the family whether the present patient meets criteria or whether the service can provide the required longitudinal care.

Antibody treatment needs a complete monitoring pathway

Writing the prescription is only one part of care. Establish who reviews baseline imaging, discusses APOE-related risk, schedules later MRI, and manages ARIA or infusion reactions. If imaging and treatment occur at different institutions, responsibility for transferring images and making decisions must be explicit. The caregiver should not have to interpret the scan and decide whether the next dose is safe. 2026 ARIA workgroup update

The monitoring plan must match the actual medicine and current applicable requirements. The July 2026 US lecanemab label specifies MRI after approximately 1, 2, 3, and 6 months of treatment; the Chinese hospital should explain the local plan it will use. “Regular follow-up” is too vague to organize care across borders. Current Leqembi label

Ask how new symptoms are handled outside working hours and how the treatment team obtains information from a local emergency department. Severe sudden symptoms should not be left untreated while trying to return to the original center. Before leaving China, establish that a clinician at home will take responsibility for the next decisions, not merely that an MRI machine is available nearby.

Multidisciplinary review should address a defined problem

Joint assessment may help when cognitive difficulties intersect with mood, sleep, neurological signs, medication burden, or other diseases. West China's published memory-MDT description explains a coordinated approach, while its broader MDT information describes screening of records. This is a reminder that a multidisciplinary consultation should have a clinical question to resolve. West China memory MDT

Ask what written conclusion the consultation will produce, which existing tests are sufficient, and whether the patient and a care partner familiar with the history should attend. Historical webpage schedules, locations, or prices should be reconfirmed rather than used as a current booking instruction. For a clearer clinical problem, a specialist visit with selected referrals may be more appropriate than an MDT at every appointment.

Useful coordination means that opinions are reconciled into a plan. Receiving several separate recommendations without anyone explaining how they fit together may still leave the family unable to act. Identify the clinician who will communicate the combined conclusions and arrange the next review.

Behavioral symptoms and caregiving deserve their own consultation time

Tell the clinic in advance if the pressing problem is wandering at night, fearfulness, refusal of care, or severe agitation. Assessment needs to consider pain, delirium, surroundings, and communication as well as medicines. Anding Hospital's published services include multidisciplinary and nursing support, making them a relevant enquiry route; this article does not confirm that every listed service is available to every overseas patient.

The treatment plan should define the target difficulty, when it will be reassessed, and how excessive sleepiness or falls will be handled. NICE recommends ongoing psychosocial and environmental measures to reduce distress, with clear review of medication decisions. Keeping a person asleep all day is not by itself evidence of successful behavioral treatment. NICE NG97 recommendations

Care partners may need practical teaching, not just a new prescription. Ask whether someone can demonstrate communication approaches, review troublesome care situations, or advise on a routine that is realistic in the home. The patient's needs and the caregiver's capacity should both be visible in the plan.

International services involve more than translation

PUMCH publishes an official guide to international patient appointments and related services. Other institutions should likewise confirm passport registration, record language, accompaniment, test bookings, and payment arrangements through their own channels. An international-service label does not establish that cognitive testing is available in the patient's language or that insurance has authorized the treatment. PUMCH international patient guide

Explain whether interpretation is needed for the history, formal cognitive testing, written reports, or all three. These functions may require different arrangements. Keep the original reports and imaging even when a translated summary is accepted; repeated translation can obscure important details. Confirm treatment-specific statements with the clinical team that will actually provide care.

A trial-site listing is not access to a purchasable treatment

An international registry can identify a research project and participating hospitals. Enrollment still follows the individual protocol. Chinese sites listed for a study such as TRONTIER 1 do not guarantee access to its investigational drug, exemption from randomization, or suitability compared with established options. TRONTIER 1 registration

Separate research screening from routine care. Ask about study purpose, visit demands, cost responsibilities, and care after withdrawal. A registration number is not efficacy approval, and previous participation by a hospital does not confirm open places now. Verify both the current study status and the site's response before building a travel plan around it.

Compare recommendations using the same questions

After consultations, compare how clearly each plan explains the diagnosis, rationale for treatment, monitoring, expected burden, and continuation at home. If opinions differ, identify whether the disagreement concerns stage, imaging, interpretation of biomarkers, or inconsistent information about daily function. This can show whether another assessment would add value.

Consider the distance, the availability of a consistent care partner, and whether records can move reliably between teams. One appointment at a distant specialist center may not provide all subsequent care. Connecting specialist advice with day-to-day management at home often makes the plan more executable than repeatedly changing hospitals. NIA care guidance